SCHEMBL6157876

SCHEMBL6157876

C=CC(=O)OC(=O)CCCCCN

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.43
LMNA P02545 3/20 0.43
THRB P10828 2/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
PLG P00747 1/20 0.43
ALOX15 P16050 1/20 0.43
SLC6A2 P23975 1/20 0.43
RECQL P46063 1/20 0.43
SLC6A3 Q01959 1/20 0.43
PAOX Q6QHF9 2/20 0.42
TSHR P16473 7/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.40
NFKB1 P19838 1/20 0.40
BLM P54132 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
CYP1A2 P05177 2/20 0.38
HPGD P15428 1/20 0.33
TP53 P04637 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16950293 1.00 ALDH1A1 (0.43) ALDH1A1LMNATHRBKMT2AMEN1
SCHEMBL17337913 0.98 ALDH1A1 (0.42) ALDH1A1LMNATHRBKMT2AMEN1
SCHEMBL2776924 0.90 TSHR (0.48) ALDH1A1LMNATSHRCYP3A4HPGD
SCHEMBL28495861 0.88 TSHR (0.44) ALDH1A1LMNATSHRCYP3A4HPGD
SCHEMBL6157826 0.84 TSHR (0.37) ALDH1A1THRBTSHRCYP3A4CYP1A2
SCHEMBL588136 0.83 TSHR (0.44) ALDH1A1LMNATHRBTSHRCYP3A4
SCHEMBL3347194 0.82 ABCC4 (0.50) ALDH1A1LMNATHRBKMT2AMEN1
SCHEMBL4758861 0.81 LMNA (0.56) ALDH1A1LMNATHRBKMT2AMEN1
SCHEMBL7250811 0.81 LMNA (0.56) ALDH1A1LMNATHRBKMT2AMEN1
SCHEMBL20767099 0.81 LMNA (0.56) ALDH1A1LMNATHRBKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11883007-B2 Controlled motion capsule COYLE BRIAN MICHAEL (US) 2024-01-30 US claimed
US-20230043450-A1 Controlled Motion Capsule COYLE BRIAN MICHAEL (US) 2023-02-09 US claimed
CN-106573015-B Enteric elastomer 麻省理工学院 2021-11-26 CN claimed
US-11083690-B2 Enteric elastomers MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2021-08-10 US claimed
EP-3154553-B1 ENTERIC ELASTOMERS MASSACHUSETTS INST TECHNOLOGY (US) 2020-08-05 EP claimed
US-20200030234-A1 ENTERIC ELASTOMERS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2020-01-30 US claimed
US-10413507-B2 Enteric elastomers MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2019-09-17 US claimed
CN-110106692-A A kind of method for the noniron finish enhancing cotton fabric tearing brute force 合肥巧织纺织科技有限公司 2019-08-09 CN claimed
US-20170128576-A1 ENTERIC ELASTOMERS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2017-05-11 US claimed
US-20170106099-A1 RESIDENCE STRUCTURES AND RELATED METHODS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2017-04-20 US claimed
EP-3155024-A1 RESIDENCE STRUCTURES AND RELATED METHODS Massachusetts Institute Of Technology (US) 2017-04-19 EP claimed
EP-3154553-A1 ENTERIC ELASTOMERS Massachusetts Institute Of Technology (US) 2017-04-19 EP claimed
WO-2015191922-A1 ENTERIC ELASTOMERS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2015-12-17 WO claimed
WO-2015191920-A1 RESIDENCE STRUCTURES AND RELATED METHODS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2015-12-17 WO claimed
US-20050165136-A1 Glass-ionomer cements containing amino acids UAB RESEARCH FOUNDATION (US) 2005-07-28 US claimed
EP-1503717-A1 GLASS-IONOMER CEMENTS CONTAINING AMINO ACIDS The UAB Research Foundation (US) 2005-02-09 EP claimed
US-6794467-B2 CROSSLINKING; FREE RADICAL CATALYST; SWELLING WITH ALCOHOL; DISPOSABLE PRODUCTS; DIAPERS, SANITARY NAPKINS COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2004-09-21 US claimed
WO-2003061606-A1 GLASS-IONOMER CEMENTS CONTAINING AMINO ACIDS UAB RESEARCH FOUNDATION (US) 2003-07-31 WO claimed
EP-4719179-A2 MANUFACTURING METHODS FOR GASTRIC RESIDENCE SYSTEMS Nortiva Bio, Inc. (US) 2026-04-08 EP disclosed
WO-2003061606-A1 GLASS-IONOMER CEMENTS CONTAINING AMINO ACIDS UAB RESEARCH FOUNDATION (US) 2003-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170106099-A1 RESIDENCE STRUCTURES AND RELATED METHODS SI, VIP, GIPR ALDH1A1 1973/4885LMNA 655/4885THRB 2959/4885
US-20200030234-A1 ENTERIC ELASTOMERS SI, GNE, MLN ALDH1A1 2982/4885LMNA 1601/4885THRB 4836/4885
US-20170128576-A1 ENTERIC ELASTOMERS SI, GNE, MLN ALDH1A1 2982/4885LMNA 1601/4885THRB 4836/4885
US-11083690-B2 Enteric elastomers SI, GNE, MLN ALDH1A1 2982/4885LMNA 1601/4885THRB 4836/4885
US-10413507-B2 Enteric elastomers SI, GNE, MLN ALDH1A1 2982/4885LMNA 1601/4885THRB 4836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.